GAS6 and COVID-19: Furthermore, the results obtained in this study highlighted a decrease, even if not statistically significant, of Gas6 plasma levels over time [77], thus supporting the assumption that this molecule behaves as an acute-phase molecule [10,11], playing an important role in COVID-19-related hypercytokinemia and the altered coagulation state, typical of severe disease conditions [96,97].